---
title: "On-demand webinar: Mini-Organs, Major Breakthroughs: Accelerating Oncology Drug Development"
description: "On-demand webinar: Mini-Organs, Major Breakthroughs: Accelerating Oncology Drug Development"
image: https://resources.huborganoids.nl/hubfs/assets2024/webinar-mini-organs.jpg
---

[![Logo HUB Organoids](https://resources.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "Logo HUB Organoids")](https://huborganoids.nl/)

![merk-m-logo-blue](https://resources.huborganoids.nl/hs-fs/hubfs/merk-m-logo-blue.png?width=728&height=225&name=merk-m-logo-blue.png)

On-demand webinar

# Mini-Organs, Major Breakthroughs: Accelerating Oncology Drug Development

![](https://resources.huborganoids.nl/hs-fs/hubfs/assets2024/webinar-mini-organs.jpg?width=400&name=webinar-mini-organs.jpg)Patient-derived organoids are viewed as the gold standard in bridging the gap between the lab and the clinic. The latest technological advancements are using patient material to generate “mini-organs” in a dish, revolutionizing *in vitro* predictivity. This innovative approach is proving to be superior to conventional 2D cell cultures and animal models, which fail to recapitulate patient tumor biology either due to a lack of cellular complexity or fundamental species differences. Co-culturing tumor organoids with immune and stromal cells offers a unique opportunity to interrogate novel immuno-therapies, derived from both tumor and normal tissue.

#### Download this to explore:

- The latest 3D *in vitro* systems for oncology drug development
- Application of 3D organoids and organoid-based co-cultures
- Compelling case studies showcasing the efficacy of implementing the right screening platforms for guiding the development of clinical candidates
- And more

### Watch now

![Logo HUB Organoids](https://resources.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "Logo HUB Organoids")

[Privacy Policy](https://huborganoids.nl/privacy-policy)

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

***FOR RESEARCH USE ONLY.**  Unless otherwise stated in our catalog or other company documentation  
 accompanying the product(s), our products are intended for research use only and are not to be used   
 for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro   
 diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to   
humans or animals.*